SB-742,457

From Self-sufficiency
Revision as of 17:49, 30 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s): nervous-system-drug-stub)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
SB-742,457
File:SB-742457-structure.png
Systematic (IUPAC) name
3-phenylsulfonyl-8-(piperazin-1-yl)quinoline
Clinical data
Routes of
administration
Oral
Legal status
Legal status
  • Uncontrolled
Identifiers
CAS Number 607742-69-8
ATC code none
PubChem CID 11256720
Chemical data
Formula C19H19N3O2S
Molar mass 353.44 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

SB-742,457 is a selective 5-HT6 receptor antagonist with cognition, memory, and learning-enhancing effects.[1][2][3][4] It is currently under development by GlaxoSmithKline for the treatment of Alzheimer's disease and has demonstrated preliminary efficacy in phase II clinical trials.[3][4][5]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />


  1. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  2. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  3. 3.0 3.1 Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  4. 4.0 4.1 Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  5. "Search of: SB-742457 - List Results - ClinicalTrials.gov".